Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on anti-epileptic drug (phenytoin) absorption

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 6, 2012, Pages 550-557

  Ponnala, Shivani ^a,b   Chaudhari, Jaydip Ray ^c   Jaleel, Momin Abdul ^c   Bhiladvala, Dilnawaz ^c   Kaipa, Prabhakar Rao ^b   Das, Undurti N ^d   Hasan, Qurratulain ^c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b OSMANIA UNIVERSITY   (India)

^c KAMINENI HOSPITALS   (India)

^d UND Life Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; MULTIDRUG RESISTANCE PROTEIN 1; PHENYTOIN;

ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DRUG ABSORPTION; FEBRILE CONVULSION; FEMALE; GENE FREQUENCY; GENOTYPE; GRAND MAL SEIZURE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION DENSITY; PRESCHOOL CHILD; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; INDIA; INFANT; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PHENYTOIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, GABA-A; SEIZURES; SEIZURES, FEBRILE; YOUNG ADULT;

EID: 84859250966     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0225     Document Type: Article

References (41)

1. Allabi AC, Gala JL, Horsmans Y (2005) CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population. Pharmacogenet Genomics 15:779-786. (Pubitemid 41531727)
2. Amara SG, Sonders MS (1998) Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend 51:87-96. (Pubitemid 28353758)
3. Anglicheau D, Verstuyft C, Laurent-Puig P, et al. (2003) Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol 14:1889-1896. (Pubitemid 36750485)
4. Balram C, Sharma A, Sivathasan C, et al. (2003) Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates. Br J Clin Pharmacol 56:78-83. (Pubitemid 36886491)
5. Baulac S, Huberfeld G, Gourfinkel-An I, et al. (2001) First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 28:46-48. (Pubitemid 32405815)
6. Bear MF, Connors BW, Paradiso MA (2011) Neuroscience: Exploring the Brain. Lippincott, Williams & Wilkins, Hagerstown, MD.
7. Bowser DN, Wagner DA, Czajkowski C, et al. (2002) Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy. Proc Natl Acad Sci U S A 99:15170-15175. (Pubitemid 35334628)
8. Chou IC, Lee CC, Tsai CH, et al. (2007) Association of GABRG2 polymorphisms with idiopathic generalized epilepsy. Pediatr Neurol 36:40-44. (Pubitemid 46427790)
9. Das SK, Biswas A, Roy T, et al. (2006) A random sample survey for prevalence of major neurological disorders in Kolkata. Indian J Med Res 124:163-172. (Pubitemid 44515797)
10. Dericioglu N, Babaoglu MO, Yasar U, et al. (2008) Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene. Epilepsy Res 80:42-46.
11. Hapmap (2003) Available at www.hapmap.org/hapmap populations.html.
12. Hoffmeyer S, Burk O, von RO, et al. (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97:3473-3478. (Pubitemid 30183327)
13. Hung CC, Tai JJ, Lin CJ, et al. (2005) Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics 6:411-417. (Pubitemid 40916364)
14. International League Against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30:389-399.
15. Ito M, Yamakawa K, Sugawara T, et al. (2006) Phenotypes and genotypes in epilepsy with febrile seizures plus. Epilepsy Res 70 Suppl 1:S199-S205.
16. Kananura C, Haug K, Sander T, et al. (2002) A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol 59:1137-1141. (Pubitemid 34755827)
17. Kang JQ, Shen W, Macdonald RL (2009) The GABRG2 mutation, Q351 •, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression. J Neurosci 29:2845-2856.
18. Kim RB (2002) Transporters and xenobiotic disposition. Toxicology 181-182:291-297.
19. Korpi ER, Grunder G, Luddens H (2002) Drug interactions at GABA(A) receptors. Prog Neurobiol 67:113-159.
20. Kumari R, Lakhan R, Kalita J, et al. (2010) Association of alpha subunit of GABAA receptor subtype gene polymorphisms with epilepsy susceptibility and drug resistance in north Indian population. Seizure 19:237-241.
21. Kwan P, Brodie MJ (2007) Emerging drugs for epilepsy. Expert Opin Emerg Drugs 12:407-422. (Pubitemid 47518376)
22. Leschziner G, Jorgensen AL, Andrew T, et al. (2006) Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study. Lancet Neurol 5:668-676. (Pubitemid 44062410)
23. Marchi N, Hallene KL, Kight KM, et al. (2004) Significance of MDR1 and multiple drug resistance in refractory human epileptic brain. BMC Med 2:37.
24. Marzolini C, Paus E, Buclin T, et al. (2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75:13-33. (Pubitemid 38130115)
25. Nakamura T, Sakaeda T, Horinouchi M, et al. (2002) Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 71:297-303. (Pubitemid 34311459)
26. Pauli-Magnus C, Kroetz DL (2004) Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1). Pharm Res 21:904-913.
27. Ponnala S, Rao KP, Chaudhury JR, et al. (2009) Effect of polyunsaturated fatty acids on diphenyl hydantoin-induced genetic damage in vitro and in vivo. Prostaglandins Leukot Essent Fatty Acids 80:43-50.
28. Ramasamy K, Sisy SS, Chandrasekaran A (2006) Allele and genotype frequency of MDR1 C3435T in Tamilian population. Drug Metab Pharmacokinet 21:506-508.
29. Regesta G, Tanganelli P (1999) Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 34:109-122. (Pubitemid 29155481)
30. Sakaeda T, Nakamura T, Okumura K (2002) MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol Pharm Bull 25:1391-1400. (Pubitemid 39663152)
31. Sakaeda T, Nakamura T, Okumura K (2003) Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics 4:397-410. (Pubitemid 36857176)
32. Seo T, Ishitsu T, Ueda N, et al. (2006) ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics 7:551-561. (Pubitemid 43891412)
33. Shahwan A, Murphy K, Doherty C, et al. (2007) The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy Res 73:192-198. (Pubitemid 46331873)
34. Siddiqui A, Kerb R, Weale ME, et al. (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 348:1442-1448. (Pubitemid 36407173)
35. Sieghart W, Fuchs K, Tretter V, et al. (1999) Structure and sub-unit composition of GABA(A) receptors. Neurochem Int 34:379-385. (Pubitemid 29240634)
36. Sisodiya SM, Lin WR, Harding BN, et al. (2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125:22-31. (Pubitemid 34084034)
37. Sukhai M, Piquette-Miller M (2000) Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci 3:268-280.
38. Tan NC, Heron SE, Scheffer IE, et al. (2004) Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 63:1090-1092. (Pubitemid 39287923)
39. Tishler DM, Weinberg KI, Hinton DR, et al. (1995) MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36:1-6.
40. Wallace RH, Marini C, Petrou S, et al. (2001) Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28:49-52. (Pubitemid 32405816)
41. Whiting PJ (2003) The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Dev 6:648-657.